In CLL, tumor-derived EVs are shown to up-regulate the expression of ICAM-1, CXCL1, and IL-34 in endothelial cells, leading to angiogenesis and CLL proliferation [140]. Here, IL34 is linked to B-cell chronic lymphocytic leukemia.